---
audience:
- professional
- researcher
authors:
- Jack Waserman
- Samarthji Lal
- Serge Gauthier
content_type: research_paper
doi: 10.1136/jnnp.46.1.75
journal: Journal of Neurology, Neurosurgery, and Psychiatry
patient_friendly: false
primary_category: tourette
publication_date: 1983 Jan
reading_level: academic
scraping_date: '2025-10-21T17:50:20.025411'
source: PMC Web Scraping
source_url: https://pmc.ncbi.nlm.nih.gov/articles/PMC1027267
title: Gilles de la Tourette's syndrome in monozygotic twins
type: research_paper
---
# Gilles de la Tourette's syndrome in monozygotic twins

**Authors:** Jack Waserman, Samarthji Lal, Serge Gauthier

**Journal:** Journal of Neurology, Neurosurgery, and Psychiatry
**Publication Date:** 1983 Jan
**DOI:** 10.1136/jnnp.46.1.75

## Abstract

Concordance is reported of Gilles de la Tourette syndrome in a male twin pair in whom phenotyping revealed a >98·7% probability that they were monozygotic. The development and extent of the illness differed markedly in the two subjects. Our findings are compatible with the view that there is a genetic form of Gilles de la Tourette syndrome.

## Full text

PDF

## Selected References

These references are in PubMed. This may not be the complete list of references from this article.




Bremness A. B., Sverd J. Methylphenidate-induced Tourette syndrome: case report. Am J Psychiatry. 1979 Oct;136(10):1334–1335. doi: 10.1176/ajp.136.10.1334. [DOI] [PubMed] [Google Scholar]

ELLISON R. M. GILLES DE LA TOURETTE'S SYNDROME. Med J Aust. 1964 Feb 1;1:153–155. [PubMed] [Google Scholar]

Escalar G., Majeron M. A., Finavera L., Zamberletti P. Contributo alla coinoscenza della sindrome di Gilles de la Tourette. Studio su due gemelli. Minerva Med. 1972 Sep 15;63(64):3517–3522. [PubMed] [Google Scholar]

Fras I., Karlavage J. The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children. Am J Psychiatry. 1977 Feb;134(2):195–197. doi: 10.1176/ajp.134.2.195. [DOI] [PubMed] [Google Scholar]

Friedhoff A. J. Receptor sensitivity modification (RSM)--a new paradigm for the potential treatment of some hormonal and transmitter disturbances. Compr Psychiatry. 1977 Jul-Aug;18(4):309–317. doi: 10.1016/0010-440x(77)90001-3. [DOI] [PubMed] [Google Scholar]

Golden G. S. The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol. 1977 Jul;2(1):69–70. doi: 10.1002/ana.410020113. [DOI] [PubMed] [Google Scholar]

Pollack M. A., Cohen N. L., Friedhoff A. J. Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy. Arch Neurol. 1977 Oct;34(10):630–632. doi: 10.1001/archneur.1977.00500220064011. [DOI] [PubMed] [Google Scholar]

Sleator E. K. Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome. Clin Pediatr (Phila) 1980 Jul;19(7):453–454. doi: 10.1177/000992288001900704. [DOI] [PubMed] [Google Scholar]

Wassman E. R., Eldridge R., Abuzzahab S., Sr, Nee L. Gilles de la Tourette syndrome: clinical and genetic studies in a midwestern city. Neurology. 1978 Mar;28(3):304–307. doi: 10.1212/wnl.28.3.304. [DOI] [PubMed] [Google Scholar]

Wilson R. S., Garron D. C., Klawans H. L. Significance of genetic factors in Gilles de la Tourette syndrome: a review. Behav Genet. 1978 Nov;8(6):503–510. doi: 10.1007/BF01067479. [DOI] [PubMed] [Google Scholar]

---

## Research Details

**Source:** PMC Web Scraping
**Category:** tourette
**Source URL:** https://pmc.ncbi.nlm.nih.gov/articles/PMC1027267
**Scraping Date:** 2025-10-21T17:50:20.025411

*This paper was scraped from PMC search results and processed for the neurodevelopmental disorders knowledge base.*